Core Viewpoint - The U.S. pharmaceutical stocks are experiencing declines following President Trump's letter urging major drug companies to reduce their prices to match those in other countries [1] Group 1: Stock Performance - GlaxoSmithKline is down 0.4% [1] - Eli Lilly and Novartis are both down 0.5% [1] - Pfizer has decreased by 0.7% [1] - AstraZeneca is down 1.6% [1] - Sanofi has dropped 1.7% [1] - Novo Nordisk is down 2.3% [1] Group 2: Government Action - President Trump sent letters to 17 major pharmaceutical companies, including Eli Lilly, Novo Nordisk, and Pfizer [1] - The letters urge these companies to immediately lower the prices they charge for drugs under the Medicaid program [1] - Trump demands that future drug prices be aligned with those in other countries [1]
美股异动丨医药股盘前集体下跌，诺和诺德跌超2%，特朗普要求降低药品价格
Ge Long Hui·2025-08-01 08:55